Ray Co

Ray Co OCF Margin

The Operating Cash Flow Margin of Ray Co (228670.KQ) as of Nov 18, 2026 is 11.54 %. In the previous year, Operating Cash Flow Margin was 0.26 % — a change of 4,406.38% (higher).

OCF Margin

11.54 %

YoY

4,406.38%

Last updated:

Operating Cash Flow Margin of Ray Co is 2025 11.54 % . Operating Cash Flow Margin of Ray Co was 2024 0.26 % . It decreases by 4,406.38% higher compared to the previous year.

The Ray Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
8.34 KRW
Jan 1, 2019
8.26 KRW
Jan 1, 2020
5.26 KRW
Jan 1, 2021
12.37 KRW
Jan 1, 2022
-6.38 KRW
Jan 1, 2023
-15.62 KRW
Jan 1, 2024
0.26 KRW
Jan 1, 2025
11.54 KRW
The Ray Co OCF Margin history
YEAROCF MarginYoY
11.54 %+4,406.38%
0.26 %-101.64%
-15.62 %+144.84%
-6.38 %-151.59%
12.37 %+135.16%
5.26 %-36.34%
8.26 %-0.94%
8.34 %+149.35%
3.34 %+52.28%
2.20 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

Operating Cash Flow Margin of Ray Co is 11.54 % in 2025.

Operating Cash Flow Margin of Ray Co changed from 0.26 % to 11.54 %, representing a 4,406.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Ray Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Ray Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Ray Co

All Key Metrics — Ray Co